
Cambridge biotech Alchemab Therapeutics has extended its Series A round with a £25 million ($34 million) investment from the British Business Bank, which the company says is the state-owned lender’s largest backing of a life sciences company to date. T…

ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to the private equity firm Frazier Healthcare Partners for $490m in cash. The deal lets the medical-device maker part with a unit it had owned for years to focus o…

Utah has quietly become the first US state to let an AI chatbot renew prescriptions without a doctor, according to the Associated Press. The programme, run by a company called Doctronic, launched in January and has set off a fierce medical debate. Resi…

Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised $14m to do it in America. CurifyLabs has closed a $14m (€12m) Series A, the company announced. T…

Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to $1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay $1.1bn upfront, w…

Scientists in Minnesota have built a cell from scratch. It can feed, grow, and divide, and it competes with its own offspring. Its makers do not claim it is alive. But the line between chemistry and biology just got a lot thinner. The team at the Unive…

A Silicon Valley startup says it has built a pharmacy with no pharmacist behind the counter. Sealed bottles go in, filled and checked prescriptions come out, in about a minute. The company, Queue, came out of stealth on Tuesday with a working machine a…

The US government has just handed scientists the largest map of human health ever assembled. It pairs more than half a million genomes with real medical records, and it arrives as the programme behind it faces deep budget cuts. The database comes from …